chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Narrative: 73 yo male with PIVIH BPH, chronic backpain, dyslipidemia, osteopenia and migraine who reported bilateral leg weakness after receiving his second Moderna vaccine on 2/09/2021. Patient was then referred to neurology and pain specialists. Per note, they have not found the reason for his bilateral weakness. Unsure if it correlates to the vaccine. Per neurology recommendation, patient should try stopping atorvastatin for a short period. Of note, patient received the booster dose on December 10, 2021.
This spontaneous case was reported by a consumer and describes the occurrence of RASH ERYTHEMATOUS (red rash) and RASH PRURITIC (itchy (rash)) in an 80-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 012L20A) for COVID-19 vaccination.     No medical history provided by Reporter.  Concomitant products included ADALIMUMAB (HUMIRA), METHOTREXATE and PREDNISONE for an unknown indication.    On 01-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 11-Feb-2021, the patient experienced RASH ERYTHEMATOUS (red rash) and RASH PRURITIC (itchy (rash)). At the time of the report, RASH ERYTHEMATOUS (red rash) and RASH PRURITIC (itchy (rash)) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No treatment information provided by Reporter.   Most recent FOLLOW-UP information incorporated above includes: On 22-Apr-2021: TCR received contains no new information
Hair started falling out; Got a dry cough; Felt like he would run out of oxygen; Foggy brain; Weak; Sweating at night; Temporary loss of taste; Lost smell; Chills; Tired; This spontaneous case was reported by a patient and describes the occurrence of ALOPECIA (Hair started falling out), COUGH (Got a dry cough), DYSPNOEA (Felt like he would run out of oxygen), FEELING ABNORMAL (Foggy brain) and ASTHENIA (Weak) in a 74-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 031M20A and 031M20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included COVID-19 (Had Covid-19 in Nov2020.).   On 09-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 10-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 13-Jul-2021, the patient experienced ALOPECIA (Hair started falling out), COUGH (Got a dry cough), DYSPNOEA (Felt like he would run out of oxygen), FEELING ABNORMAL (Foggy brain), ASTHENIA (Weak) and FATIGUE (Tired). 13-Jul-2021, the patient experienced HYPERHIDROSIS (Sweating at night), AGEUSIA (Temporary loss of taste), ANOSMIA (Lost smell) and CHILLS (Chills). At the time of the report, ALOPECIA (Hair started falling out), COUGH (Got a dry cough), DYSPNOEA (Felt like he would run out of oxygen), FEELING ABNORMAL (Foggy brain), ASTHENIA (Weak), HYPERHIDROSIS (Sweating at night), AGEUSIA (Temporary loss of taste), ANOSMIA (Lost smell), CHILLS (Chills) and FATIGUE (Tired) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): In November 2020, SARS-CoV-2 test: positive (Positive) Positive.         This case was linked to MOD-2021-032822 (Patient Link).
This spontaneous report as received from a nurse via company representative refers to a 68 year old female patient. Medical history and current conditions were not reported. Concomitant medications were not reported. On 25-AUG-2016 the patient was vaccinated with PNEUMOVAX23 (dose, route, anatomical location and lot # were unknown) for prophylaxis. On 07-SEP-2016, the patient presented back to the office with cough and congestion that lasted for 6 days. On the 8-SEP-2016 she returned to office, feeling worse and was sent for an x-ray next day (data not showed). The doctor suspected pneumonia and the patient was diagnosed in the hospital or emergency room, and treated with unspecified antibiotic and the patient progressively got worse. On an unknown date in 2016, just a couple of days after that, the patient presented in the emergency room and ended up staying a week in the hospital, conflicting information reported as "02 sat of 84". The pneumonia was ruled out and doctor decided that it was a severe reaction, respiratory distress reaction to PNEUMOVAX 23. The patient was alive and was dismissed from the emergency room. The outcome of respiratory distress was unknown. The reporter considered the event respiratory distress to be related to the suspect therapy. Upon internal review, the event respiratory distress was determined to be medically significant. As of 09-DEC-2016, all telephone attempts to obtain follow-up information have been unsuccessful. Additional information has been requested. Sender's Comments: MERCK 1611USA007545: Mfr number.
I woke up at 4 AM the morning after the shot with uncontrollable shivering. When I woke again at 6 AM, the shivering started again, along with general weakness and nausea.
Varivax given SC to left anterior thigh. 3 day later, she went ER for swelling of thigh. Seen at the clinic on 10/29-redness and swelling on left thigh lap anterior portion with ringed yellow papules. Clusters of yellow on ingunial fold. Serous fluid from 1 papule. Not tender. Warm, but no limp. Also red and swollen on right mid thigh. red macule on abdomen. Started her  on po Benadryl. Seen following day-decreased swelling and redness.
Tachycardia; mild rash on the back; This spontaneous case was reported by a consumer and describes the occurrence of TACHYCARDIA (Tachycardia) and RASH (mild rash on the back) in a 75-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 10-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 10-Jan-2021, the patient experienced TACHYCARDIA (Tachycardia) and RASH (mild rash on the back). The patient was treated with DIPHENHYDRAMINE HYDROCHLORIDE (BENADRYL [DIPHENHYDRAMINE HYDROCHLORIDE]) for Rash, at a dose of UNK dosage form. At the time of the report, TACHYCARDIA (Tachycardia) outcome was unknown and RASH (mild rash on the back) had resolved. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant Medications were not provided by the reporter.; Sender's Comments: Based on the current available information and temporal association between the use of the product and the start date of these events, a causal relationship cannot be excluded.
61-year-old patient was given a high dose flu vaccine dose instead of a regular flu dose vaccine. Patient stated that they had a severe headache for approximately one day that improved with rest and staying hydrated with water.
First dose of vaccine administered after excursion; This spontaneous case was reported by an other health care professional and describes the occurrence of PRODUCT TEMPERATURE EXCURSION ISSUE (First dose of vaccine administered after excursion) in a 54-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 031A21A) for COVID-19 vaccination.     No Medical History information was reported.    On 11-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 11-Mar-2021, the patient experienced PRODUCT TEMPERATURE EXCURSION ISSUE (First dose of vaccine administered after excursion). At the time of the report, PRODUCT TEMPERATURE EXCURSION ISSUE (First dose of vaccine administered after excursion) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   Concomitant drug was not reported. Treatment medication was not reported.  it was reported that vaccine was administered to people with fluctuating temperature.   This case was linked to MOD-2021-250505 (Patient Link).
onset of 2 episoes projectile vomiting, rash over entire body, unconsolable crying x 3 hrs; taken to ER: t99.1; 1 1/2cc DPH prescribed;
Information has been received from a consumer and a school nurse concerning 41 child patients who in approximately 1995 were each vaccinated with a dose of varicella virus vaccine live. In approximately 2003, the patients developed mild cases of chickenpox.  Most of the children were in the first grade and had been vaccinated at their private pediatrician's offices in the area. The reporter noted that her elementary school was the only one out of six in the area that has experienced a chickenpox outbreak. The reporter notified the elementary school parents of the outbreak. Follow up information from the nurse indicated that 13 of the reported 41 patients were not previously vaccinated with a dose of varicella virus vaccine live and all of the cases of chickenpox have recovered. One of the previously vaccinated patients was a 6 year old patient who on 28APR1997 was vaccinated with a dose of varicella virus vaccine live. On 15MAR2003, the patient developed chickenpox. The previously vaccinated patients included two siblings in elementary school who were vaccinated by the same pediatrician and subsequently developed mild outbreaks of chickenpox. The other patients that developed chickenpox post vaccination with varicella virus vaccine live were also identified.  Additional information is not expected.
Patient received the vaccination in 2 doses. They gave him the Pfizer. He was 12 years old at the time. He received the first dose on 11/23/21 and the second dose on 12/14/21. I noticed a difference in his walking in Jan/2022. I scheduled him a Dr. appointment with his Dr. office. They then referred us to local Neurology Specialist where the process begin. My son have been through cat scans, spinal taps, physical therapy, IVIG treatments which he is on now. They diagnosed him with CIDP (chronic inflammatory demyelinating polyneuropathy).  Ever since this vaccine he have not been able to walk by himself. He have to use a walker due to the weakness and sensory loss of his legs. Before the vaccine he was a number 1 athlete in basketball, soccer, and football. Now he can not run at all.
mom states pt was found in bed w/foam @ mouth, stiff, & high fever ( mom did not take temp but pt felt hot); pt given APAP a/nap; EMS called & pt was transported to hosp; pt treated for OM; MD recommended DT in future; pt tremble while walk
Chills and uncontrollable shivering; Kept me awake; Slept most of the next day; Temperature rose to 100.5 degrees/fever; Very lethargic; No appetite; No bowel movements; Soreness at the injection site; This is a spontaneous report from a contactable consumer (patient). A 73-year-old male patient received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Lot number: EL9263; Expiration date was not reported) on 22Jan2021 (14:45) at a single dose on the left arm, with route of administration unspecified, for COVID-19 immunization at the public health clinic/veterans administration facility. Medical history included large B-cell lymphoma (recovered); chemotherapy from an unspecified date to Jul2020; and had a bad case of pneumonia from Oct2020 to an unspecified date. Concomitant medications included meloxicam, latanoprost and paracetamol (TYLENOL). On 23Jan2021 (01:00), the patient was very lethargic; had no appetite; and no bowel movements. On 23Jan2021 (23:45), the patient had soreness at the injection site; chills and uncontrollable shivering; was kept awake, and had slept most of the next day; and had fever/temperature rose to 100.5 degrees. The patient had received treatment for all the reported events. The outcome of the events, 'lethargic', 'no appetite', 'no bowel movements', 'soreness at the injection site', 'chills and uncontrollable shivering', 'kept awake and slept most of the next day' and 'fever', was recovered in Jan2021. The patient was not diagnosed with COVID-19 prior to vaccination, and was not tested post-vaccination.
Lightheaded & dizzy, slumped to floor jerky movements of arms & body rigid, skin cool & clammy;
Symptoms start 12 hour after injection with fever 101f lasting 12 hours.  With muscle pain in left arm lasting 5 days.  And mild shortness of breath lasting duration of fever.  With general fatigue lasting 4 days.
A rash devoloped at the injection site and spread radially outward until stopping at elbow and shoulder.  Pt said rash was extremely itchy.  Pt took Benadryl to help with the pruritis.  Benadryl helped.  Rash started to resolve on the third day and appears to be getting better at this time, 5th day from injection time.
fatigue; huge bruise; sore, tender arm; severe chills; This spontaneous case was reported by a consumer and describes the occurrence of CONTUSION (huge bruise), PAIN IN EXTREMITY (sore, tender arm), CHILLS (severe chills) and FATIGUE (fatigue) in a 64-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 016C21A) for COVID-19 vaccination.     Concurrent medical conditions included Rheumatoid arthritis. Concomitant products included NAPROXEN SODIUM (ALEVE) and PARACETAMOL (TYLENOL) for Rheumatoid arthritis.    On 24-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 24-Mar-2021, the patient experienced PAIN IN EXTREMITY (sore, tender arm) and CHILLS (severe chills). On 25-Mar-2021, the patient experienced CONTUSION (huge bruise). On an unknown date, the patient experienced FATIGUE (fatigue). On 25-Mar-2021, PAIN IN EXTREMITY (sore, tender arm) had resolved. On 26-Mar-2021, CHILLS (severe chills) had resolved. At the time of the report, CONTUSION (huge bruise) had not resolved and FATIGUE (fatigue) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Treatment information, if any, was not provided by the reporter.   Most recent FOLLOW-UP information incorporated above includes: On 07-Jul-2021: Additional information added include a new event.
Subsequent to receiving  the second dose of Lymerix the pt experienced bad reactions whenever she received a bug bite. The bite broke out and scabbed up leaving scars. A doctor visit was required and the pt was treated with lindane which didn't really help. As of 10/20/2000 the outcome of the event is ongoing.
The evening I recieved the J&J vaccine I began having very bad chills. I had a fever of 102. By the next morning I had a very bad headache and body aches. all of these subsided approximately at approximately 5pm the next night.
INCORRECT PRODUCT STORAGE; ADMINISTRATION OF EXPIRED VACCINE DUE TO TEMPERATURE EXCURSTION; This spontaneous report received from a pharmacist concerned a 52 year old male. The patient's height, and weight were not reported. No past medical history or concurrent conditions were reported. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: 1808986 expiry: 02-OCT-2021) dose was not reported, administered on 02-JUN-2021 for prophylactic vaccination on left arm. No concomitant medications were reported.  On 02-JUN-2021, the patient experienced administration of expired vaccine due to temperature excurstion. On an unspecified date, the patient experienced incorrect product storage. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The outcome of the administration of expired vaccine due to temperature excurstion and incorrect product storage was not reported. This report was non-serious. This case, from the same reporter is linked to 20210915852, 20210915731, 20210916228, 20210916312, 20210916300, 20210916455, 20210916553, 20210916697, 20210915748, 20210916401, 20210916849, 20210916811, 20210915661, 20210916965, 20210916498, 20210916465, 20210916415, 20210916129, 20210916910, 20210915719, 20210917074, 20210916520, 20210916907, 20210916658, 20210916584, 20210916959, 20210917226, 20210916768, 20210917163, 20210915623, 20210913164, 20210917160, 20210917515, 20210917500, 20210917515 and 20210917603.
Patient fainted with 30 seconds of administration . Parents explained that patient did not have enough to eat or drink this morning . Parents and patient waited 15 minutes after vaccination and patient felt much better after ingestion food and water
Joint pain in hip, limping, inability to walk, crankiness, crying  Called doctor's office, gave motrin.
Picture was taken Thursday evening and by Friday her rash was starting to coalesce to the point it looked like a raised sunburn. Patient was sick on July 26th, 2007. She had a high temp and was c/o a sore throat. On Friday July 27th, she was seen by her pediatrician. It was at that point that she was Dx with having strep. She was placed on Amoxicil 2x a day for 7 dys. On July 30th she received her required vaccines for school. She immediately c/o burning on the left side where the DTaP was given and even the next day she said that arm really hurt. On August 1st, 2007 she developed the patchy rash that was seen in the first email I sent to you on her left arm. I dropped her off to my mom at 7:00 am on August 2nd. There was no sign of a rash at that time. I notified the doctor when they opened and the office wanted her to come in so that they could document the reaction in her chart. She was scheduled to be seen by the pediatrician on August 3rd, 2007 at 3:15 pm. I received a phone call from my mom at 10:30 on August 2nd, 2007 stating that patient had a rash on her face. Immediately called the doctors office back and she was seen at 11:30 on August 2nd. The rash began progressing from her face and chest to her abdomen, arms, and legs to her palms of her hands and the soles of her feet. As we were waiting in the office she began c/o of her chest hurting and having problems breathing. The doctor placed her on Benadryl 1 6 hours and then steroids q 12 hours for 5 days with a taper. She had a follow-up the next day with Dr. Please let me know if you need any other information with regards to this. Mother.
Information has been received from a physician concerning a patient who on an unknown date was vaccinated with a dose of ROTATEQ.  On an unspecified date, post vaccination, the patient experienced diarrhea and was hospitalized (length of stay unspecified).  At the time of the report the patient's status was unknown.  A product quality complaint was not involved.  This is one of several reports received from the same source.  Additional information has been requested.
Possible pericarditis. Substernal chest pain worse with inspiration and laying down starting 1 week after 2nd COVID vaccine. Normal EKG. Physical exam is normal/negative.
Zoster injection - rash presentation; itch, redness; localized to injection site area (back of upper arm); approx 5 inches x 3 inches in size; rash slightly above site of injection.
Information has been received from a nurse concerning an adult patient of unknown gender. The patient's medical history, concomitant medications, concurrent conditions and drug reactions/allergies were not provided. On an unknown date, the patient was vaccinated with a third dose of a pediatric dose of RECOMBIVAX HB (strength, frequency, route of administration, lot# and expiration date were not provided), for prophylaxis. No adverse symptoms were reported. Additional information has been requested.
Extremely heavy, long lasting (9+ days) menstruation.  IMPORTANT TO NOTE: I was in the initial stage of menopause, have not have a period for over 10 months
FEELING TIRED; This spontaneous report received from a patient concerned a male of unspecified age. The patient's weight, height, and medical history were not reported. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: Unk) dose was not reported, administered on 12-MAR-2021 for prophylactic vaccination. The batch number was not reported. The Company is unable to perform follow-up to request batch/lot numbers.   No concomitant medications were reported. On MAR-2021, the subject experienced feeling tired. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The outcome of feeling tired was not reported. This report was non-serious.
Swollen knot on arm and red area underneath vaccination site.  Warm to touch, and patient reports it as painful.
Chills; Fever; nausea; Muscle pains; Based on the current case data, this case has been classified as invalid. This spontaneous case was reported by a consumer and describes the occurrence of CHILLS (Chills), PYREXIA (Fever), NAUSEA (nausea) and MYALGIA (Muscle pains) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 08-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 08-Feb-2021, the patient experienced CHILLS (Chills), PYREXIA (Fever), NAUSEA (nausea) and MYALGIA (Muscle pains). The patient was treated with PARACETAMOL (TYLENOL) at a dose of 1 dosage form. At the time of the report, CHILLS (Chills), PYREXIA (Fever), NAUSEA (nausea) and MYALGIA (Muscle pains) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No relevant concomitant medications were reported.
Patient fainted. Treated by EMT's. Taken to ER (was awake and responsive).
No adverse event; Administered the vaccine to 346 patients after the 30 day by used; Vaccine was stored in refrigerator on 26-Jun-2022 and was administered on 09-Jul-2022; This spontaneous case was reported by a health care professional and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Administered the vaccine to 346 patients after the 30 day by used), PRODUCT STORAGE ERROR (Vaccine was stored in refrigerator on 26-Jun-2022 and was administered on 09-Jul-2022) and NO ADVERSE EVENT (No adverse event) in an 86-year-old patient of an unknown gender who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 058A22-2A) for COVID-19 prophylaxis.     No Medical History information was reported.    On 26-Jul-2022, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) .25 milliliter. On 26-Jul-2022, the patient experienced EXPIRED PRODUCT ADMINISTERED (Administered the vaccine to 346 patients after the 30 day by used) and PRODUCT STORAGE ERROR (Vaccine was stored in refrigerator on 26-Jun-2022 and was administered on 09-Jul-2022). On an unknown date, the patient experienced NO ADVERSE EVENT (No adverse event). At the time of the report, EXPIRED PRODUCT ADMINISTERED (Administered the vaccine to 346 patients after the 30 day by used), PRODUCT STORAGE ERROR (Vaccine was stored in refrigerator on 26-Jun-2022 and was administered on 09-Jul-2022) and NO ADVERSE EVENT (No adverse event) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter considered NO ADVERSE EVENT (No adverse event) to be not related. No further causality assessments were provided for EXPIRED PRODUCT ADMINISTERED (Administered the vaccine to 346 patients after the 30 day by used) and PRODUCT STORAGE ERROR (Vaccine was stored in refrigerator on 26-Jun-2022 and was administered on 09-Jul-2022).    No concomitant medication were reported. The vial was initially stored in the refrigerator was on 4Jun2022. The vial didn't undergo any temperature excursions. No treatment information were provided.
SYNCOPAL EPISODE ~45 SECONDS HEART RATE - 68 BPM SP02 - 99% BP -110/78
Pt & MOP presented back to clinic 20 min after receiving vaccines c/o itching all over, no SOA, no hives. Pt skin ashen from scratching. Vitals 124/96, 118, 24, O2-100%. Pt given BENADRYL 50mg IM, MOP sent to pharmacy to pick up Rx - ATARAX PO.
12FEB96 recv vax & 23FEB96 day 11 h/a, noc sweat, w/fever;25FEB-26FEB day 13-14 above sx resolved but pt devel erythematous rash on face;mouth sore also found;28FEB96 pt reported sore gland behind lt ear;MD felt case of measles;